Skip to main content
Log in

Modification of Gelatin Beadlets for Zero-Order Sustained Release

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

A three-phase suspension process was used for the preparation of gelatin beadlets containing succinylsulfathiazole. When the beadlets were hardened with 10% formalin at 5°C for varying periods of time up to 24 hr, the 6-hr hardening time gave the slowest release rate. Drug release rate from gelatin beadlets was slower in simulated gastric fluid (SGF) than in simulated intestinal fluid (SIF) but the sustained effect was too limited to be useful for most applications. When the hardened gelatin beadlets were coated with cellulose acetate butyrate (CAB) by an emulsion–solvent evaporation method, a more pronounced sustained effect and a nearly zero-order release were found in SIF. The effects of the amount of gelatin used, the amount of CAB employed, and the length of hardening time on drug release were investigated. The treatment of gelatin beadlets with formalin reduced the swelling action of gelatin in aqueous medium. A nonzero-order drug release rate was observed when the gelatin swelled sufficiently to rupture the CAB coating. The drug release rate can be adjusted by using different ratios of hardened gelatin beadlets and CAB coating in which the gelatin enhances the release rate and the CAB serves as a barrier.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. L. A. Luzzi. J. Pharm. Sci. 59:1367–1376 (1970).

    Google Scholar 

  2. P. L. Madan. In T. Kondo (ed.), Microencapsulation: New Techniques and Application, Techno, Tokyo 1979, pp. 11–34.

  3. J. R. Nixon and M. A. M. Hassan. Drug Dev. Ind. Pharm 7:305–316 (1981).

    Google Scholar 

  4. J. M. Conrad and J. R. Robinson. In H. A. Lieberman and L. Lachman (eds.), Pharmaceutical Dosage Forms: Tablets, Vol. 3, Marcel Dekker, New York, 1982, pp. 149–211.

    Google Scholar 

  5. S. Reynolds. U.S. Patent 2,183,084 (1939).

  6. N. Tanaka, S. Takino, and I. Utsumi. J. Pharm. Sci. 52:664–667 (1963).

    Google Scholar 

  7. G. N. Paradissis and E. L. Parrott. J. Clin. Pharm. 8:54–59 (1968).

    Google Scholar 

  8. S. Goto, M. Komatsu, K. Tagawa, and M. Kawata. Chem. Pharm. Bull. 31:256–261 (1983).

    Google Scholar 

  9. S. E. Leucuta. Drug Dev. Ind. Pharm. 12:2281–2288 (1986).

    Google Scholar 

  10. J. R. Nixon, S. A. H. Khalil, and J. E. Carless. J. Pharm. Pharmacol. 20:528–538 (1968).

    Google Scholar 

  11. S. A. H. Khalil and S. S. El Gamal. Acta Pharm. Suec. 8:423–430 (1971).

    Google Scholar 

  12. P. L. Madan, D. K. Madan, and J. C. Price. J. Pharm. Sci. 65:1476–1479 (1976).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiao, C.S.L., Price, J.C. Modification of Gelatin Beadlets for Zero-Order Sustained Release. Pharm Res 6, 517–520 (1989). https://doi.org/10.1023/A:1015980809952

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015980809952

Navigation